PMID- 27932984 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220316 IS - 1663-9812 (Print) IS - 1663-9812 (Electronic) IS - 1663-9812 (Linking) VI - 7 DP - 2016 TI - Curcumin Suppressed Activation of Dendritic Cells via JAK/STAT/SOCS Signal in Mice with Experimental Colitis. PG - 455 LID - 455 AB - Dendritic cells (DCs) play a pivotal role as initiators in the pathogenesis of inflammatory bowel disease and are regulated by the JAK/STAT/SOCS signaling pathway. As a potent anti-inflammatory compound, curcumin represents a viable treatment alternative or adjunctive therapy in the management of chronic inflammatory bowel disease (IBD). The mechanism of curcumin treated IBD on DCs is not completely understood. In the present study, we explored the mechanism of curcumin treated experimental colitis by observing activation of DCs via JAK/STAT/SOCS signaling pathway in colitis mice. Experimental colitis was induced by 2, 4, 6-trinitrobenzene sulfonic acid. After 7 days treatment with curcumin, its therapeutic effect was verified by decreased colonic weight, histological scores, and remitting pathological injury. Meanwhile, the levels of major histocompatibility complex class II and DC costimulatory molecules (CD83, CD28, B7-DC, CD40, CD40 L, and TLR2) were inhibited and followed the up-regulated levels of IL-4, IL-10, and IFN-gamma, and down-regulated GM-CSF, IL-12p70, IL-15, IL-23, and TGF-beta1. A key finding was that the phosphorylation of the three members (JAK2, STAT3, and STAT6) of the JAK/STAT/SOCS signaling pathway was inhibited, and the three downstream proteins (SOCS1, SOCS3, and PIAS3) from this pathway were highly expressed. In conclusion, curcumin suppressed the activation of DCs by modulating the JAK/STAT/SOCS signaling pathway to restore immunologic balance to effectively treat experimental colitis. FAU - Zhao, Hai-Mei AU - Zhao HM AD - School of Basic Medical Sciences, Jiangxi University of Traditional Chinese Medicine Nanchang, China. FAU - Xu, Rong AU - Xu R AD - Department of Postgraduate, Jiangxi University of Traditional Chinese Medicine Nanchang, China. FAU - Huang, Xiao-Ying AU - Huang XY AD - Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine Nanchang, China. FAU - Cheng, Shao-Min AU - Cheng SM AD - School of Basic Medical Sciences, Jiangxi University of Traditional Chinese Medicine Nanchang, China. FAU - Huang, Min-Fang AU - Huang MF AD - Department of Postgraduate, Jiangxi University of Traditional Chinese Medicine Nanchang, China. FAU - Yue, Hai-Yang AU - Yue HY AD - Department of Postgraduate, Jiangxi University of Traditional Chinese Medicine Nanchang, China. FAU - Wang, Xin AU - Wang X AD - Department of Postgraduate, Jiangxi University of Traditional Chinese Medicine Nanchang, China. FAU - Zou, Yong AU - Zou Y AD - Department of Postgraduate, Jiangxi University of Traditional Chinese Medicine Nanchang, China. FAU - Lu, Ai-Ping AU - Lu AP AD - School of Chinese Medicine, Hong Kong Baptist University Kowloon Tong, China. FAU - Liu, Duan-Yong AU - Liu DY AD - Science and Technology College, Jiangxi University of Traditional Chinese Medicine Nanchang, China. LA - eng PT - Journal Article DEP - 20161125 PL - Switzerland TA - Front Pharmacol JT - Frontiers in pharmacology JID - 101548923 PMC - PMC5122716 OTO - NOTNLM OT - JAK/STAT/SOCS signal OT - costimulatory molecules OT - curcumin OT - dendritic cell OT - experimental colitis EDAT- 2016/12/10 06:00 MHDA- 2016/12/10 06:01 PMCR- 2016/11/25 CRDT- 2016/12/10 06:00 PHST- 2016/08/28 00:00 [received] PHST- 2016/11/14 00:00 [accepted] PHST- 2016/12/10 06:00 [entrez] PHST- 2016/12/10 06:00 [pubmed] PHST- 2016/12/10 06:01 [medline] PHST- 2016/11/25 00:00 [pmc-release] AID - 10.3389/fphar.2016.00455 [doi] PST - epublish SO - Front Pharmacol. 2016 Nov 25;7:455. doi: 10.3389/fphar.2016.00455. eCollection 2016.